SARS-CoV-2-specific hotspots in virus-host interaction networks

. 2021 Jul;22(7):806-808.

doi: 10.1038/s41590-021-00963-9.

Herbert B Schiller¹, Merlijn van Breugel^{2

3

4}, Martijn C Nawijn^{5

6}

Affiliations

¹ Comprehensive Pneumology Center, Institute of Lung Biology and Disease, Helmholtz Zentrum München, Member of the German Center for Lung Research (DZL), Munich, Germany.
² MIcompany, Amsterdam, the Netherlands.
³ Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
⁴ GRIAC Research Institute, University Medical Center Groningen, Groningen, the Netherlands.
⁵ GRIAC Research Institute, University Medical Center Groningen, Groningen, the Netherlands. m.c.nawijn@umcg.nl.
⁶ Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. m.c.nawijn@umcg.nl.

Herbert B Schiller et al. Nat Immunol. 2021 Jul.

. 2021 Jul;22(7):806-808.

doi: 10.1038/s41590-021-00963-9.

Herbert B Schiller¹, Merlijn van Breugel^{2

3

4}, Martijn C Nawijn^{5

6}

¹ Comprehensive Pneumology Center, Institute of Lung Biology and Disease, Helmholtz Zentrum München, Member of the German Center for Lung Research (DZL), Munich, Germany.
² MIcompany, Amsterdam, the Netherlands.
³ Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
⁴ GRIAC Research Institute, University Medical Center Groningen, Groningen, the Netherlands.
⁵ GRIAC Research Institute, University Medical Center Groningen, Groningen, the Netherlands. m.c.nawijn@umcg.nl.
⁶ Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. m.c.nawijn@umcg.nl.

No abstract available

Cited by

Targeting the Ubiquitylation and ISGylation Machinery for the Treatment of COVID-19.
Vere G, Alam MR, Farrar S, Kealy R, Kessler BM, O'Brien DP, Pinto-Fernández A. Vere G, et al. Biomolecules. 2022 Feb 12;12(2):300. doi: 10.3390/biom12020300. Biomolecules. 2022. PMID: 35204803 Free PMC article. Review.
Emergence of a unique SARS-CoV-2 Delta sub-cluster harboring a constellation of co-appearing non-Spike mutations.
Banerjee A, Mazumder A, Roy J, Das J, Majumdar A, Chatterjee A, Biswas NK, Chawla Sarkar M, Das S, Dutta S, Maitra A. Banerjee A, et al. J Med Virol. 2023 Jan;95(1):e28413. doi: 10.1002/jmv.28413. J Med Virol. 2023. PMID: 36541745 Free PMC article.
Post-treatment with propofol inhibits inflammatory response in LPS-induced alveolar type II epithelial cells.
Yang X, Ma L. Yang X, et al. Exp Ther Med. 2022 Apr;23(4):249. doi: 10.3892/etm.2022.11174. Epub 2022 Jan 31. Exp Ther Med. 2022. PMID: 35261621 Free PMC article.
Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing.
Luedemann M, Stadler D, Cheng CC, Protzer U, Knolle PA, Donakonda S. Luedemann M, et al. Comput Struct Biotechnol J. 2022;20:799-811. doi: 10.1016/j.csbj.2022.01.024. Epub 2022 Jan 29. Comput Struct Biotechnol J. 2022. PMID: 35126884 Free PMC article.

1. Bösl, K. et al. Front. Immunology 10, 2186 (2019). - DOI
1. Stukalov, A. et al. https://doi.org/10.1038/s41586-021-03493-4 (2021).
1. George, P. M., Wells, A. U. & Jenkins, R. G. Lancet Respir. Med. 8, 807–815 (2020). - DOI
1. Melms, J. C. et al. Nature https://doi.org/10.1038/s41586-021-03569-1 (2021). - DOI - PubMed
1. Reyna, M. A., Leiserson, M. D. M. & Raphael, B. J. Hierarchical HotNet: identifying hierarchies of altered subnetworks. Bioinformatics 34, i972–i980 (2018). - DOI